Leena Mithal

Associate Professor

Ann and Robert H Lurie Children's Hospital of Chicago
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (4)

Bronchopulmonary dysplasia (BPD) is the most common respiratory disease in preterm infants born at less than 28 weeks gestation. Most existing clinical prediction models for BPD show limited accuracy in predicting BPD development when validated using external data, stressing the need for novel biomarkers to identify at-risk infants for early and effective interventions. We leveraged existing frozen umbilical cord blood samples from the Northwestern University Cord Blood Biobank (NUCord) to perform parallel transcriptional and DNA methylation profiling. BPD-associated differentially expressed genes (DEGs) in our cohort included markers previously established in clinical and animal BPD studies, such as genes related to NF-κB signaling and immune responses. We also identified that BPD development is associated with disrupted methylation signatures in microRNA genes and genes associated with glucose metabolism. Our results suggest that BPD development is associated with distinct transcriptomic and epigenetic signatures when compared with healthy term and preterm infants. These signatures may represent biomarkers measurable at birth that predict BPD development during a time window when preventative or therapeutic interventions could be applied.

Year:

2025

Preterm infants are at high risk for systemic inflammatory disorders, including sepsis, meningitis, bronchopulmonary dysplasia, and necrotizing enterocolitis (NEC). The developing brain of the premature newborn is especially susceptible to the cascade of inflammatory mediators elaborated in these conditions that cross the blood-brain barrier. NEC, a severe and potentially fatal condition of the gut that occurs in premature newborns, is a prime example of how an inflammatory reaction, perhaps initially localized, can become generalized and cause systemic harm. One such result is brain injury, especially to the cerebral white matter, which may lead to neurodevelopmental abnormality and dysregulated behavior. Numerous studies have documented an association between necrotizing enterocolitis and neurodevelopmental impairment (NDI), but to date, the brain and behavioral deficits associated with neonatal NEC are not fully understood. We performed a comprehensive systematic review and meta-analysis of existing literature to characterize brain injury and behavioral alterations associated with NEC. 7153 peer-reviewed published manuscripts were screened by two independent reviewers and evidence quality was assessed using GRADE criteria. Of these papers, 62 satisfied the criteria for our review (i.e., no case reports, meta-analyses, systematic reviews, or animal studies). Data from 32 papers using Bayley Scales of Infant and Toddler Development to assess infant outcomes were included in the meta-analysis. Our findings support neonatal necrotizing enterocolitis having deleterious effects on brain and behavioral development and impact on cognitive function, risk of cerebral palsy and motor impairment, educational achievement, behavior, and neuroanatomy. We discuss herein findings of both short-term outcomes (1-3 years) and long-term outcomes (until 13 years). Our meta-analysis also indicates that NEC has a moderate effect size on infant development, with consistent impairment across mental, cognitive, language and motor domains. WHAT DO THE FINDINGS OF THIS REVIEW MEAN? In this review, we describe several short-term and long-term neurodevelopmental outcomes of preterm infants with NEC. These findings suggest that infants with NEC should be monitored with close developmental follow-up so that individuals can receive appropriate testing that may prompt therapies and qualify them to receive early intervention services. HOW UP TO DATE IS THIS REVIEW? The review authors searched for studies published up to 2021. Abstracts with no data available were excluded, so this review does not consider any new findings published from 2022-2024.

Year:

2024

Background Multi-drug resistant Enterobacterales, in particular with ceftriaxone resistance (CefR-E), are globally prevalent. Pregnant people colonized with resistant Enterobacterales are at risk of perinatally transmitting to neonates; infections with CefR-E strains are associated with higher mortality, morbidity and health care costs. This study aimed to estimate the rate of gut colonization of AmpR-E (ampicillin resistant Enterobacterales) and CefR-E in a population of healthy mother-infant dyads in the Chicago area and investigate the genetic characteristics of CefR-E. Methods Pregnant persons anticipating vaginal birth at two Chicago area hospitals were enrolled. Patients with preterm delivery (<35 weeks), fever during labor, cesarean delivery, exposure to antibiotics in 3rd trimester, and neonatal intensive care were excluded. Pregnancy and birth history were obtained from parent and medical record. Maternal vaginal and rectal swabs, and infant stool samples were collected and screened for resistance by plating on MacConkey with ceftriaxone. Whole genome sequencing (WGS) and analysis was conducted on the CefR-E isolates. Results Between July 2020 and April 2022, 261 mother-infant dyads were enrolled with 184 maternal samples and 157 infant stool samples analyzed. Rate of maternal AmpR-E gut colonization was 97% (179/184). Rate of maternal and infant CefR-E gut colonization was 14% (26/184) and 7% (11/157) respectively. Perinatal transmission of CefR-E was 50% (11 of 22) positive mothers with available infant sample). No clinical variables were significantly associated with maternal CefR-E colonization or perinatal transmission. Type of infant nutrition (breastmilk) was significantly associated with decreased perinatal transmission of AmpR-E to infant (p=0.015). WGS of the CefR-E showed that 19/42 isolates were E. coli , and transmission primarily occurred from mothers colonized with E. coli . Conclusions This study demonstrates that a sizable minority of pregnant persons are colonized with CefR-E in the U.S., a higher burden than previously reported for developed countries. Enterobacterales appear adept in perinatal transmission, with half of infants born to colonized pregnant persons harboring CefR-E in first week of life.

Year:

2024

Neonatal health is dependent on early risk stratification, diagnosis, and timely management of potentially devastating conditions, particularly in the setting of prematurity. Many of these conditions are poorly predicted in real-time by clinical data and current diagnostics. Umbilical cord blood may represent a novel source of molecular signatures that provides a window into the state of the fetus at birth. In this study, we comprehensively characterized the cord blood proteome of infants born between 24 to 42 weeks using untargeted mass spectrometry and functional enrichment analysis. We determined that the cord blood proteome at birth varies significantly across gestational development. Proteins that function in structural development and growth (e.g., extracellular matrix organization, lipid particle remodeling, and blood vessel development) are more abundant earlier in gestation. In later gestations, proteins with increased abundance are in immune response and inflammatory pathways, including complements and calcium-binding proteins. Furthermore, these data contribute to the knowledge of the physiologic state of neonates across gestational age, which is crucial to understand as we strive to best support postnatal development in preterm infants, determine mechanisms of pathology causing adverse health outcomes, and develop cord blood biomarkers to help tailor our diagnosis and therapeutics for critical neonatal conditions.

Year:

2024

Collaborators (2)

Hiam Abdala Valencia

Associate Professor

Northwestern University

UNITED STATES
View details

Benjamin Singer

Vice Chair for Research, Department of Medicine; Lawrence Hicks Professor of Pulmonary Medicine; Associate Professor of Medicine & Biochemistry and Molecular Genetics

Northwestern University Feinberg School of Medicine

UNITED STATES
View details